Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Int J Pharm
; 515(1-2): 684-691, 2016 Dec 30.
Article
em En
| MEDLINE
| ID: mdl-27825863
Palavras-chave
Arginine; Caprylocaproyl macrogol-8 glycerides (Labrasol(®)); Carbopol 940 (PubChem CID 6581, Acrylic Acid); Deformable liposomes; Excised human skin; Glycerol distearate (Precirol(®) ATO 5); In vitro skin permeation; Nanostructured lipid carriers (NLC); Oxaprozin; Oxaprozin (PubChem CID 4614); Polyoxyethylene sorbitan monoleate (PubChem CID 86289060); Randomly methylated ß-cyclodextrin; Randomly-methylated-ß-cyclodextrin (PubChem CID 122143); Sodium cholate (PubChem CID 23668194); Stearylamine (PubChem CID 15793); l-Arginine (PubChem CID 6322)
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Propionatos
/
Portadores de Fármacos
/
Ciclodextrinas
/
Nanopartículas
/
Lipídeos
/
Lipossomos
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article